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Melanocytic Galectin-3 Is Associated with
Tyrosinase-Related Protein-1 and Pigment Biosynthesis
Allison Chalupa1,3, Amy Koshoffer1,3, Emily Galan1, Lan Yu2, Fu-Tong Liu2 and Raymond E. Boissy1
Galectin-3 is a family member of the carbohydrate-binding proteins widely expressed by many cell types and
exhibits multiple cellular functions. We demonstrate that melanocytes express galectin-3, which is predominantly
localized to the cell body peripherally along the Golgi zone. Downregulation of galectin-3 in human melanocytes
using short hairpin RNA technology resulted in the reduction of both melanin synthesis and expression/activity
of tyrosinase-related protein-1 (Tyrp-1). In the cell body, galectin-3 colocalizes with melanosome-destined cargo,
specifically tyrosinase and Tyrp-1. We studied melanocytes cultured from patients with forms of Hermansky–
Pudlak syndrome (HPS) containing defects in trafficking steps governed by biogenesis of lysosome-related
organelle complex-2 (BLOC-2) (HPS-5), BLOC-3 (HPS-1), and adaptin-3 (HPS-2). We found that galectin-3
expression mimicked the defective expression of the tyrosinase cargo in dendrites of HPS-5 melanocytes, but
it was not altered in HPS-1 or HPS-2 melanocytes. In addition, galectin-3 colocalized predominantly with the HPS-
5 component of BLOC-2 in normal human melanocytes. These data indicate that galectin-3 is a regulatory
component in melanin synthesis affecting the expression of Tyrp-1.
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INTRODUCTION
The melanocyte synthesizes a premelanosome organelle
derived from the endosomal system within the cell (Marks
and Seabra, 2001). Subsequently, several enzymes (specifically
tyrosinase, tyrosinase-related protein-1 (Tyrp-1), and Tyrp-2)
and regulatory proteins that are responsible for converting
tyrosine to melanins are trafficked from the Golgi apparatus,
through the endosomal system, and targeted for incorporation
to the premelanosome (Boissy et al., 2006; Raposo and Marks,
2007). Predominate chaperones that facilitate this traffick-
ing process are the family of protein complexes called
BLOCs (biogenesis of lysosome-related organelles complex)
(Dell’Angelica 2004; Di Pietro et al., 2006). Many of the
subunits of these BLOCs are products of genes that when
mutated result in the Hermansky–Pudlak syndrome (HPS)
(Bonifacino, 2004; Di Pietro and Dell’Angelica 2005; Wei,
2006). BLOC-2 is composed of at least the HPS-3, -5, and -6
proteins (Di Pietro et al., 2004) and BLOC-3 is composed of at
least the HPS-1 and -4 proteins (Nazarian et al., 2003; Kloer
et al., 2010). When mutated, each of these HPS proteins
compromise the integrity of their respective BLOCs and impair
efficient trafficking of the requisite enzyme to the melanosome
in a distinctive manner, resulting in reduced melanin synthesis
and cutaneous and ocular hypopigmentation (Richmond et al.,
2005; Boissy et al., 2006). The molecular mechanisms used by
these BLOCs to recruit and shuttle melanosome-destined
cargo remains unclear. However, two small GTPase, Rab32
and Rab38, have recently been shown to cooperate with
BLOC-2 and/or BLOC-3 in trafficking of melanogenic
enzymes (Marks, 2012; Bultema and DiPietro, 2013). Also
unknown are additional protein and regulatory components
that may be part of or participate with BLOCs.
Galectin-3 is a member of carbohydrate-binding proteins
that interact primarily with b-galactoside residues of cell
surface and extracellular matrix glycoprotein molecules
(Wang et al., 2004; Dumic et al., 2006). By virtue of this
property, galectin-3 has been implicated in cell–cell and cell–
substrate recognition. In addition, it has been proposed that
galectin-3 may function as a chaperone involved in intracel-
lular trafficking of cytosolic glycoproteins in various cell types
(Liu et al., 2002; Delacour et al., 2006, 2009; Vagin et al.,
2009). Expression of galectin-3 by the melanocytes has
not been reported. However, brief mention of galectin-3
being a possible component of the melanosome was
demonstrated in melanosomes purified using sucrose density
gradient centrifugation and subsequently analyzed by protein
digestion and mass spectrometry (Basrur et al., 2003).
In this report, we demonstrate that galectin-3 is expressed
by melanocytes, regulates melanogenesis, maintains the
expression of Tyrp-1, and colocalizes to chaperones upstream
of the melanosome, particularly HPS-5, in the melanocyte cell
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body. These data implicate galectin-3 as a regulator of
melanization by maintaining Tyrp-1.
RESULTS
Expression of galectin-3 by epidermal cells
Galectin-3 was identified at the expected molecular weight of
30 kDa in cultured melanocytes from both light- and dark-
skinned individuals (Figure 1aA1). Galectin-3 was also identi-
fied in an established line of human melanoma cells, cultured
human keratinocytes, and fibroblasts, as well as in epidermal
lysates from dark and light skin. The 30-kDa galectin-3
molecule expressed by cultured melanocytes was not found
to be secreted into the medium (Figure 1aA2).
Silencing of galectin-3 results in reduced melanin synthesis
Cultures of normal human melanocytes (NHMs) derived from
dark, medium, and light skins were silenced for galectin-3
expression by transfection with several short hairpin RNAs
(shRNAs), as described in Materials and Methods section. The
dark line (1800 ng melanin per ug protein) and the medium line
(800 ng melanin per ug protein) were silenced using the Santa
Cruz shRNA (Supplementary Figure 1 online) and the light line
(25 ng melanin per ug protein) was silenced using the Sig-
maTRCN clones (Figure 1b). Galectin-3 was markedly reduced
in all cell lines by 25–40%. Concurrently, melanin amount was
significantly reduced in all melanocyte lines by 20–50%
compared with the control shRNA transfectants (Figure 1c).
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Figure 1. (a) Expression and secretion of galectin-3 by cutaneous cells and tissues. (A1) Galectin-3 of 30 kDa was identified by immunocytochemistry in lysates of
dark (E-dk) and light (E-lt) neonatal foreskins and in cultured cells of skMel melanoma (Sk), dermal fibroblasts (Fb), keratinocytes (K), and melanocytes derived from
light (M-lt) and dark (M-dk) skin. (A2) Medium collected from light skin–derived melanocytes before (Me) or after (Me-a) acetone precipitation did not exhibit the
30-kDa galectin-3. However, the latter did exhibit a 45- to 50-kDa triplet and a 250-kDa doublet. (Bk, blank lane). (b, c) Silencing of galectin-3 results in reduced
melanin synthesis. Cultured melanocytes derived from one light skin was transfected with control shRNA (Mock) or one of six galectin-3 shRNAs (304-8). The
amount of (b) galectin-3 protein and (c) melanin content was reduced in the galectin-3-silenced melanocyte lines by 24–40% and 20–50%, respectively, compared
with the mock transfectants in all melanocyte lines. (d) Cellular profile of galectin-3. Cultured normal human melanocytes and skMEL melanoma cells
demonstrated a prominent perinuclear localization of galectin-3 and minimal dendritic localization. Doublet insets below the immunofluorescence micrographs
represent phase (left) and corresponding fluorescence (right) images of cells stained with the galectin-3 primary antibody omitted and secondary used to
demonstrate lack of nonspecific staining. C, cytoplasm; N, nucleus. Bars¼10mm; insets¼ 5mm.
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Cellular profile of galectin-3
In NHMs and melanoma cells, galectin-3 is expressed in a
granular pattern that is prominent within the cell body and
moderate along the dendrites, while being relatively devoid in
the nucleus (Figure 1d). There is a distinctive lattice-like and
vesicular profile in the cell body that resembles the location of
the endoplasmic reticulum and endosomes, suggesting that
galectin-3 could participate in the trafficking of glycoproteins
in this significant area.
Tyrp-1 expression and activity is reduced in galectin-3-silenced
NHMs
Cultures of NHMs derived from light skin were silenced for
galectin-3 expression by shRNA transfection, as described in
Materials and Methods section and presented in Figure 1.
Control shRNA and Gal3 shRNA transfectants exhibited and
lacked galectin-3 expression, respectively (Figure 2aB and E).
In addition, control shRNA and Gal3 shRNA transfectants
demonstrate abundant and reduced expression of Tyrp-1
throughout the cell, respectively (Figure 2aC and F). In
contrast, expression of tyrosinase was not altered in control
shRNA and Gal3 shRNA transfectants (Figure 2aG–L). Signal
intensity per cell representing the expression of Tyrp-1 in
control shRNA and Gal3 shRNA transfectants was 17
104±15 and 1.9104±0.4, respectively (P¼0.021). For
tyrosinase expression, signal intensity values were 116
104±19 and 157 104±20, respectively (P¼ 0.111).
A fourth round of silencing on a light NHM line was
performed using three of the SigmaTRCN clones and assessed
for expression of Tyrp-1 and tyrosinase. Expression of galectin-
3 was reduced by 20–30% (Figure 2b), Tyrp-1 by 20–42%
(Figure 2b), and tyrosinase (data not shown) was unchanged.
Concurrently, the tyrosine hydroxylase activity specific for
human Tyrp-1 was significantly reduced in the galectin-3-
silenced NHMs (Figure 2c). These results show that the
expression and/or maintenance of Tyrp-1, as opposed to
tyrosinase, was dependent on galectin-3.
Colocalization of galectin-3 with melanosome-destined cargo
(i.e., tyrosinase and Tyrp-1)
Galectin-3 was found to colocalize with both tyrosinase and
Tyrp-1 in NHMs (Figure 3). Both tyrosinase and Tyrp-1 had
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Figure 2. Galectin-3 influences tyrosinase related protein-1 (Tyrp-1) expression but not that of tyrosinase. (a) Cultured melanocytes derived from light skins were
transfected with control short hairpin RNA (shRNA) (Control shRNA) or galectin-3 shRNA (Gal3 shRNA) and colabeled by immunofluorescence for galectin-3 and
Tyrp-1 or tyrosinase. The amount of Tyrp-1 expression in shRNA transfectants (A, C) was reduced in the Gal3 shRNA tranfectants (D, F). In contrast, tyrosinase
expression was similar in both the shRNA transfectants (G, I) and the Gal3 shRNA transfectants (J, L). Bars¼ 40mm. (b) Cultured melanocytes transfected with
control (Mock) or three galectin-3 (305, 306, and 308) shRNAs demonstrating a reduction in expression of galectin-3 (ranging between 20 and 30%) and Tyrp-1
(ranging between 20 and 42%) by silencing. (c) Cell lines represented in (b) demonstrating a concurrent reduction in the catalytic activity of human Tyrp-1.
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similar colocalization patterns with galectin-3. The Mander’s
coefficient quantifying these colocalizations within the cell
body is presented in Table 1. In contrast, colocalization of
galectin-3 with the rough endoplasmic reticulum and the
nucleus was relatively minimal. The colocalization of galec-
tin-3 with Tyrp-1 and tyrosinase occurs lateral to the Golgi,
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Figure 3. Galectin-3 colocalizes with melanosome-destined cargo. Galectin-3 colocalizes with both tyrosinase (left panel) and tyrosinase-related protein-1
(middle panel). This colocalization is prominent in the peri-Golgi area (arrows) and does not occur in the dendrites. In contrast, the colocalization of galectin-3
with the rough endoplasmic reticulum (RER; right panel) appeared minimal. Bars¼ 30mm.
Table 1. Quantification of galectin-3 coexpression with tyrosinase and Tyrp-1
Cell type Cell area Colocalized proteins Mander’s coefficient1
NHM Cell body Galectin-3 and Tyrp-1 0.945±0.042,
NHM Cell body Galectin-3 and tyrosinase 0.977±0.01
NHM Cell body Galectin-3 and RER 0.732±0.023
NHM Cell body Galectin-3 and nucleus 0.277þ 0.013
NHM Entire cell Galectin-3 and tyrosinase 0.856±0.038
HPS-1 (BLOC-3) Entire cell — 0.647±0.1164
HPS-2 (adaptin-3) Entire cell — 0.693±0.0624
HPS-5 (BLOC-2) Entire cell — 0.864±0.101
Abbreviations: BLOC, biogenesis of lysosome-related organelle complex; HPS, Hermansky–Pudlak syndrome; NHM, normal human melanocyte; RER, rough
endoplasmic reticulum; Tyrp-1, tyrosinase related protein-1.
1Mander’s overlap coefficient ranges between 1 and 0, with 1 being high colocalization and 0 being low.
2Average plus SD.
3Po0.05 compared with galectin-3 and Tyrp-1 in cell body of NHMs.
4Po0.05 compared with galectin-3 and tyrosinase in entire cell of NHMs.
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where Golgi-derived cargo vesicles containing tyrosinase and
Tyrp-1 fuse with either endosomes or stage II melanosomes.
Galectin-3 also seemed to be somewhat restricted from the
perinuclear Golgi zone. In addition, colocalization between
galectin-3 and both tyrosinase and Tyrp-1 does not appear to
occur in the dendrites of the melanocytes. This pattern of
colocalization between galectin-3 and the two melanocyte-
specific enzymes suggests that galectin-3 may be involved in
the trafficking of these enzymes to melanosomes.
Colocalization of galectin-3 with melanosome-destined proteins
in BLOC-2, BLOC-3, and adaptin-3-deficient HPS melanocytes
HPS-1 melanocytes contain genetic mutations that prevent
the normal functioning of the BLOC-3 chaperone. These
mutations cause the HPS-1 melanocytes to express macro-
autophagosomes to which tyrosinase and Tyrp-1 are targeted
to because of their ineffective trafficking to melanosomes
(Smith et al., 2005). In HPS-1 melanocytes, galectin-3 demon-
strated varied amounts of colocalization with melanocyte-
specific proteins in HPS-1 macroautophagosomes (Figure 4a).
There was either marked, moderate, or no colocalization
observed in various cells. This suggests that galectin-3
probably does not uniquely function in the BLOC-3 regulatory
step in trafficking, but it may be incorporated into macro-
autophagosomes by default. In support of this subjective
evaluation, the Mander’s coefficient demonstrates that the
colocalization of galectin-3 with tyrosinase throughout the
entire cell is lower in the HPS-1 cells as opposed to control
NHMs (Table 1).
HPS-2 melanocytes contain genetic mutations that affect the
functioning of the adaptin-3 chaperone. These mutations
cause HPS-2 melanocytes to exhibit normal expression of
Tyrp-1 and a drastically reduced expression of tyrosinase,
which is mainly localized to multivesicular endosomes
(Huizing et al., 2001). In HPS-2 melanocytes, galectin-3
exhibited a normal colocalization pattern with Tyrp-1 in the
peri-Golgi zone (Figure 4b). Galectin-3 did not colocalize
with tyrosinase outside of the Golgi zone in multivesicular
endosomes. This suggests that galectin-3 is probably not
involved in the adaptin-3 step of cargo trafficking. In support
of this subjective evaluation, the Mander’s coefficient demon-
strates that the colocalization of galectin-3 with tyrosinase is
lower in the HPS-2 cells as opposed to control NHMs
(Table 1).
HPS-5 melanocytes contain genetic mutations that affect the
normal function of the BLOC-2 chaperone. These mutations
cause HPS-5 melanocytes to retain tyrosinase and Tyrp-1 in
many cargo vesicles that become distributed through the
dendrites and impart a fine granular pattern rather than the
normal course granular fluorescence pattern in the dendrites
(Boissy et al., 2005; Helip-Wooley et al., 2007). In HPS-5
melanocytes, galectin-3 also demonstrated the abnormal fine
granular fluorescent pattern resembling cargo vesicles and
colocalization with tyrosinase in the dendrites (Figure 4c). In
support of this subjective evaluation, the Mander’s coefficient
demonstrates that the colocalization of galectin-3 with tyrosi-
nase did not differ between the HPS-5 and the control NHMs,
in contrast to the difference in HPS-1 and HPS-2 (Table 1).
This suggests that galectin-3 may participate in BLOC-2-
regulated trafficking step that is thought to function in the
recognition, docking, and fusion of cargo vesicles with
premelanosomes.
Colocalization of galectin-3 with BLOC-2 and BLOC-3
With immunocytochemistry, galectin-3 appears to colocalize
to a greater extent, but not exclusively, to the BLOC-2
component HPS-5 compared with the BLOC-3 component
HPS-1. This is seen by a greater overall area of yellow regions
in the HPS-5 compared with the HPS-1 melanocytes
(Figure 5). This was confirmed by the quantitative analysis of
the images using MetaMorph (Supplementary Table 2 online;
Supplementary material online). In the latter study, the
analysis of the colocalization was restricted to the Golgi and
peri-Golgi areas of the melanocytes. The percentages deter-
mined by MetaMorph analysis were used in a t-test to confirm
a significant difference in the colocalization between galectin-
3 and HPS-1 versus HPS-5. MetaMorph analysis confirmed the
increase in colocalization between galectin-3 and HPS-5
compared with the colocalization between galectin-3 and
HPS-1 (Supplementary Table 2 online; Supplementary material
online). As HPS-5 is a component of BLOC-2 and HPS-1 of
BLOC-3, this suggests that galectin-3 may participate in
BLOC-2-regulated trafficking, which functions in the recogni-
tion, docking, and fusion of cargo vesicles with premelano-
somes, rather than BLOC-3-regulated trafficking.
DISCUSSION
Galectin-3 is a member of a family of carbohydrate-binding
proteins that is widely expressed by cells and with multiple
functions depending on the cell type (Wang et al., 2004).
Within the cell, galectin-3 can regulate cell growth, cell cycle,
and apoptosis via its relation to known intracellular pathways
associated with these processes (Liu et al., 2002). An
interesting and less explored cellular function of galectin-3 is
the trafficking of glycoprotein cargo through the cell. In
Madin-Darby canine kidney epithelial cells, galectin-3
contributes to delivering non-raft-dependent glycoproteins to
the lumen of lactase-phlorizen hydrolase-associated vesicles in
a carbohydrate-dependent manner, and depletion of galectin-3
results in missorting of the glycoprotein cargo (Delacour et al.,
2006). In the trafficking of non-raft-independent glycoproteins,
galectin-3 interacts directly with beta-galactoside moieties of
the cargo resulting in cross-linked clusters to facilitate
trafficking and targeting (Delacour et al., 2007).
It has previously been demonstrated that galectin-3 exists in
the melanocytes (Basrur et al., 2003), as well as in benign and
malignant melanocytic lesions (Abdou et al., 2010; Braeuer
et al., 2012). In the former report, galectin-3 was identified
using melanosomes purified by sucrose density gradient
centrifugation and subsequently analyzed by protein dige-
stion and mass spectrometry (Basrur et al., 2003). In our
present report, we confirmed that melanocytes express
galectin-3 and exhibit a distinct localization pattern pre-
valent in the cell body peripheral to the Golgi zone. This
positions galectin-3 to be a participant or chaperone in the
trafficking of melanosome-destined cargo from the Golgi
A Chalupa et al.
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Figure 4. (a) Galectin-3 expression in Hermansky–Pudlak syndrome-1 (HPS-1) melanocytes. In cultured human melanocytes from a patient with HPS-1, galectin-
3 exhibits a variation in its localization to macroautophagosomes consisting of (A1) no, (A2, A4) minimal, or (A3) prominent localization, respectively. In addition,
the colocalization of galectin-3 with either tyrosinase or tyrosinase-related protein-1 (TYRP-1) in the macroautophagosomes also varied consisting of (A1, A2) no,
(A4) minimal, or (A3) marked colocalization, respectively. Bars¼10mm; insets¼ 3mm. (b) Galectin-3 expression in HPS-2 melanocytes. In cultured human
melanocytes from a patient with HPS-2, galectin-3 expression is restricted from the HPS-2-specific macroautophagosomes that accumulate tyrosinase (arrowhead).
In contrast, colocalization of galectin-3 with TYRP-1 is normal, i.e., prevalent around the perinuclear area as depicted in Figure 2. G, Golgi zone; N, nucleus.
Bar¼10mm; insets¼5mm. (c) Galectin-3 expression in HPS-5 melanocytes. (Left doublet) In cultured human melanocytes from a patient with HPS-5, tyrosinase
exhibits the characteristic fine (arrowheads), as opposed to granular (arrows), staining pattern present in normal human melanocytes (NHMs), particularly
noticeable in the dendrites. (Center doublet) Minimal expression of galectin-3 in the dendrites of both cultured NHMs and HPS-5 melanocytes was intensified
for observation by increasing the gain of the laser during image capture. (Right doublet) In NHMs, there is minimal colocalization of galectin-3 and tyrosinase.
In contrast, in HPS-5 melanocytes, there is colocalization between galectin-3 and tyrosinase in a fine pattern (arrowheads) containing 50-nm vesicles, as opposed
to a granular pattern in NHMs. Bars¼ 10mm; insets¼2mm.
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to the premelanosome. Colocalization of galectin-3 with
tyrosinase and Tyrp-1 at the periphery of the Golgi zone
strengthens the hypothesis of this function.
BLOCs have recently been identified as trafficking compo-
nents in the biogenesis of lysosome-related organelles includ-
ing the melanosome (Dell’Angelica 2004; Di Pietro et al.,
2006). Mutations affecting the functions of BLOCs, as well
as the chaperone adaptin-3, result in distinct forms of HPS
(Richmond et al., 2005; Boissy et al., 2006). To further explore
the role of galectin-3 in trafficking during the biogenesis of
the melanosome, we analyzed the expression pattern in
melanocytes cultured from patients with HPS. As described
in the Materials and Methods section, cultured melanocytes
from each form of HPS exhibit distinct defects in the trafficking
profile of melanosome-destined cargo. Specifically, mutations
affecting BLOC-3 (i.e., HPS-1 and -4) result in the accumu-
lation of macroautophagosomes in the melanocytes where
tyrosinase and Tyrp-1 are targeted (Smith et al., 2005).
Mutations affecting BLOC-2 (i.e., HPS-3, -5, and -6) result
in the accumulation of 50-nm vesicles containing tyrosinase
and Tyrp-1 cargo throughout the cell body and dendrites,
with the inefficient incorporation of these enzymes into the
melanosome (Boissy et al., 2005; Helip-Wooley et al., 2007).
Mutations affecting adaptin-3 (i.e., HPS-2) result in the
accumulation of tyrosinase, but not Tyrp-1, in mulivescicular
bodies of the perinuclear area (Huizing et al., 2001). We
rationalized that if galectin-3 participated in the trafficking step
governed by either BLOC-3, BLOC-2, or adaptin-3, an aberrant
expression pattern for galactin-3 would result as well and
mimic that of the associated cargo in melanocytes from the
respective HPS form. The data demonstrated that only in
BLOC-2-defective HPS-5 melanocytes does the colocaliza-
tion of galectin-3 uniformly accompany that of the mistraf-
ficked cargo. A recent report demonstrated that galectin-3
expression was increased in HPS pulmonary fibrosis (Cullinane
et al., 2014).
Galectin Galectin
HPS-1 HPS-5
Merged Merged
Figure 5. Galectin-3 appears to colocalize more prominently with the biogenesis of lysosome-related organelle complex-2 (BLOC-2) component Hermansky–
Pudlak syndrome-5 (HPS-5) than the BLOC-3 component HPS-1. Immunocytochemical staining of normal human melanocytes for galectin-3 with either HPS-1
(left panel) or HPS-5 (right panel) demonstrated relatively minimal colocalization in the former (arrows) and abundant colocalization in the latter (arrowheads).
Bars¼ 50mm; insets¼10mm.
A Chalupa et al.
Galectin-3 Expression/Function in Melanocytes
208 Journal of Investigative Dermatology (2015), Volume 135
To confirm that galectin-3 is predominantly associated with
the BLOC-2 pathway, we performed quantitative analysis of the
colocalization of galectin-3 with either BLOC-2 (via association
with the HPS-5 component) or BLOC-3 (via association with
the HPS-1 component). This analysis supported the hypothesis
that galectin-3 participates primarily, but not exclusively, in the
BLOC-2 trafficking step. The inter-related roles of BLOCs and
adaptins in shuttling cargo from the trans-Golgi cisterna,
through various endosomal compartments and onto the pre-
melanosome, has yet to be clearly delineated. However, it is
predicted that these chaperone modules work in tandem and/or
concurrent pathway. It is not surprising that galectin-3 had
some association with BLOC-3 in the universal mechanism of
relaying cargo to the melanosome. Regardless, we demonstrate
in preliminary studies that downregulation of galectin-3 results
in diminished melanin synthesis and a putative mechanism
consists of the inefficient maintenance and/or targeting of at
least Tyrp-1 but not tyrosinase to melanosomes that are
ultimately translocated down the dendrites.
Galectin-3 binds galactose and lactose residues on glycopro-
teins. Tyrosinase and Tyrp-1 are replete with these sugar resi-
dues to which galectin-3 could conceivably interact (Garcı´a-
Borro´n and Solano, 2002). However, this is improbable, as the
sugar residues of Tyrp-1 and other cargo are sequestered in the
lumen of the transport vesicles and melanosomes, making them
inaccessible to cytosolic galectin-3. Of interest is a report of an
alternatively spliced form of galectin-3 that contains a single
transmembrane-spanning region and a leucine zipper-like stalk
domain that positions galectin-3 across the plasma membrane
(Gorski et al., 2002). The doublet observed for galectin-3 on
western blot analysis (Figure 1aA1) may represent galectin-3
with and without the transmembrane domain.
Galectin-3 can also participate in protein–protein interac-
tions (Liu et al., 2002) and contains proline/glycine-rich domain
(PGAYPGXXX) known to be involved in protein binding
(Pawson and Scott, 1997). Galectin-3 directly interacts with
the carboxyl terminal 50 amino acids of Gemin4, a member of
the SMN (survival of motor neuron) complex (Park et al., 2001).
Galectin-3 has been shown to bind Alix (Chen et al., 2009), a
component of the endosomal protein sorting complex pathway
required for the biogenesis of multivesicular bodies (Odorizzi,
2006). In addition, endosomal protein sorting complex is
required for Tyrp-1 transport to the melanosomal membranes
(Truschel et al., 2009), similar to BLOC-2. In conclusion, we
demonstrate that galectin-3 in the melanocyte is a candidate
chaperone molecule during melanosome biogenesis. Where
and how galectin-3 molecularly interfaces with the cargo and
known chaperones (i.e., endosomal protein sorting complex,
BLOCs, adaptins, RABs, and so on) in this pathway needs to be
explored.
MATERIALS AND METHODS
Cell culturing
Human melanocyte cultures were established from individual
neonatal foreskins obtained from the University Hospital in Cincinnati
or from the Christ Hospital in Cincinnati (IRB #03-1-23-1). Patient
consent for experiments was not required because USA laws consider
human tissue left over from surgery as discarded material. HPS cell
cultures were established from skin biopsies provided by W Gahl
(NIH, Bethesda, MD) from patients enrolled in a protocol approved
by the National Human Research Institute Review Board with written
informed consent. This study was conducted according to the
declaration of Helsinki principles. Tissues were transported to the
laboratory in DMEM with 2% antibiotic/antimycotic. Using routine
sterile techniques, the melanocytes were isolated from the tissues as
follows. Tissues were incubated in 0.25% trypsin at 4 1C overnight.
The epidermis was separated from the dermis by vortexing in
phosphate-buffered saline (PBS). The tissue was pelleted at
1,500 r.p.m. for 5 minutes at 4 1C, and the PBS supernatant was
aspirated off. The epidermis and cell suspension were resuspended in
either melanocyte or keratinocyte medium, and the dermis was
resuspended in fibroblast growth medium and plated in a T25 corning
tissue culture flask. The melanocyte growth medium consisted of
MCDB-153 medium (Sigma-Aldrich, St Louis, MO) supplemented
with 4% fetal bovine serum (Fisher Scientific, Pittsburgh, PA), 5mg ml–
1 insulin, 0.6 ng ml–1 basic fibroblast growth factor (PeproTech, Rocky
Hill, NJ), 13mg ml–1 bovine pituitary extract (Hammond Cell Tech,
Windsor, CA), 8 nM 12-O-tetradecanoylphorbol-13-acetate, and 1%
antibiotic/antimycotic (Fisher Scientific). The keratinocyte growth
medium consisted of KC Epilife supplemented with HKGS (Cascade
Biologics, Portland, OR) and 1% antibiotic/antimycotic. The fibro-
blast growth medium consisted of DMEM medium (Sigma, St Louis,
MO) supplemented with 5% fetal bovine serum, 2 mM glutamine,
0.5 mM sodium pyruvate, and 1% penicillin–streptomycin
(10,000 units ml–1 and 10,000 mg ml–1, respectively) (Gibco, Carlsbad,
CA). SKMEL-188 (a gift from R Srinivasan, Sloan-Kettering Institute for
Cancer Research, New York, NY) was maintained in the DMEM
medium supplemented with 5% fetal bovine serum, 2 mM L-glutamine
(Fisher Scientific), 1 mM sodium pyruvate (Invitrogen, Carlsbad, CA),
and 1% antibiotic/antimycotic. All the above reagents were pur-
chased from Sigma-Aldrich unless otherwise stated. Cultures were
maintained in a humidified incubator with 95% air and 5% CO2 at
37 1C. Subconfluent melanocytes and fibroblasts at passages 2–7 and
keratinocytes at passages 1–2 were used for all experiments.
Western blotting
Cells were lysed in RIPA extraction buffer and analyzed for their
protein content. Each lane on a 10% acrylaminde gel was loaded
with 30 ug of protein. After electrophoresis and transfer, the blot was
blocked in 5% milk in TNET (Tris-buffered saline-Tween) overnight,
stained with amido black and destained, and immunoblotted with
rabbit anti-galectin-3 (1:2,000) (Novus Biologicals, Littleton, CO),
mouse anti-Tyrp-1 (Mel 5, Covance, Princeton, NJ), or rabbit anti-
actin horseradish peroxidase-conjugated (Santa Cruz, Dallas, TX)
antibodies for 2 hours. The blot was washed three times in TNET
buffer, incubated in goat anti-rabbit horseradish peroxidase in 5%
milk in TNET (1:5,000 Santa Cruz), and washed twice with a final
rinse in Tris-buffered saline. The blot was then developed using a
Pierce ECL kit in a dark room (Pierce, Rockford, IL).
To assess for the secretion of galectin-3, the medium from NHM
cultures was extracted and saved, whereas the cells were trypsinized
and pelleted. One milliliter of medium was put into a centrifuge tube
along with 4 ml of  20 1C acetone. The tube was vortexed and
stored for 1 hour in a  20 1C freezer. The tube was centrifuged for
10 minutes at 13,000 r.p.m. at 4 1C. The supernatant was removed
without dislodging the protein pellet, and the extra acetone was
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allowed to evaporate from the uncapped tube in a fume hood at room
temperature for 30 minutes. A volume of 100 ul of RIPAþ PI buffer
was added to the pellet and it was vortexed to bring it to solution. This
acetone-precipitated sample was then used in a western blot as
described above.
Silencing methodology
Normal human melanocytes were plated in six-well plates at a
concentration of 2 105 per well in 1 ml of melanocyte growth
medium. The cells were incubated overnight at 37 1C, 5% CO2 to
allow them to attach. The cells were then infected with 2.5 ug ml–1
polybrene and 1.25 105 IFU shRNA. Each plate contained a well
that was not infected, plus a well that contained either control shRNA
(sh-), green fluorescent protein shRNA, or one of six different galectin-
3 shRNA. A dark line (dk) and one medium line (med) were infected
with Santa Cruz cat # sc-108080, sc-108084, and sc-155994-V in the
green fluorescent protein–infected well. A light line was infected with
one of five shRNA galectin 3 lentivirus plus a green fluorescent
protein clone and a mock shRNA clone obtained through Cincinnati
Children’s Hospital Medical Center Heart Institute’s Lenti-shRNA
Library Core. The viruses were generated using Sigma TRCN
clones TRCN0000029304, TRCN0000029305, TRCN0000029306,
TNCR0000029307, and TRCN0000029308 (Sigma). For the dk and
the med lines, the medium containing lentiviral particles was
aspirated and replaced with fresh melanocyte growth medium. For
the light line, 40 ul of virus was added and the cells were left for 5
days. A second round of infection was done with 40 ul more plus
0.8 ug ml–1 hexadimethrine bromide (Sigma H9268). After infection of
all groups, puromycin (Sigma P8833) was added at a concentration of
2 ug ml–1. The cells were treated with several rounds of puromycin
selection. After sufficient puromycin selection, the cells were used for
immunofluorescence analysis, western blot analysis, and for the
determination of melanin content.
Quantification of melanin content
Total melanin content was determined as follows. Cells were pelleted
after trypsinization and lysed (50 mM Tris pH7.54, 2 mM EDTA pH
7.87, 150 mM sodium chloride, 1% Triton-X 100) in the presence of
protease inhibitors (Complete, Roche, Indianapolis, IN). Cell extracts
were spun at 14,000 r.p.m. for 5 minutes at 4 1C. The supernatant was
removed and protein content was determined (Pierce). The pellet was
washed twice in ethanol: ether (1:1) and dissolved in 0.2 N sodium
hydroxide at 60 1C. A 75-ml aliquot was measured for absorbance at
490 nm in a plate reader (Bio-Rad, Hercules, CA).
Tyrp-1 assay
To assess the tyrosine hydroxylase activity of Tyrp-1, we used the
method developed by Zhao et al. (2004). Specifically, melanocyte
lysates (10–25mg protein) were incubated in 250ml of reaction mixture
(0.1mCi ml–1 tyrosine plus 0.08 mM unlabeled tyrosine) for 19 hours at
37 1C. Subsequently, tritium H2O produced was assessed with a
Packard 1900 CA scintillation analyzer (PerkinElmer, Shelton, CT).
Immunofluorescent methodology
Cells were plated on chamber slides at 2 104 cells per well and fixed
after 24 hours with 3% paraformaldehyde. Cells were washed with PBS
and blocked with a 5% BSA solution. Primary antibodies at optimized
concentrations in a 1% BSA/PBS solution were added to the slide and
left at room temperature for 1 hour. Cells were washed and Alexa Fluor
secondary antibodies were added at a 1:250 ratio in a 1% BSA/PBS
solution at room temperature for 45 minutes in the dark. The slide was
mounted and allowed to dry overnight before viewing on a Zeiss
LSM510 META confocal microscope (Zeiss, Thornwood, NY). The
primary antibodies used consisted of goat polyclonal antiserum to
galectin-3 provided by F-T Liu (University of California at Davis,
Sacramento, CA); rabbit polyclonal antiserum to tyrosinase provided by
R King and W Oetting (hPEP1; University of Minnesota, Minneapolis,
MN); mouse monoclonal antiserum to Tyrp-1 (Mel-5; Signet Labora-
tories, Dedham, MA); rabbit polyclonal antiserum to BiP (Santa Cruz);
rabbit polyclonal serum to the HPS-1 and HPS-5 proteins provided by
B Gahl (NIH); rabbit polyclonal antiserum to adaptin-3 provided by MS
Robinson (b3A; Cambridge Institute for Medical Research, Cambridge,
UK).
Metamorph methodology
For quantification of the expression of tyrosinase and Tyrp-1 in
control and galectin-3-silenced NHMs, captured photographs were
cropped to include the entire cell (n¼ 25 per group), and fluorescence
intensity per cell was quantified using MetaMorph (Molecular
Devices, Sunnyvale, CA) and expressed as signal intensity per cell.
For quantifying the expression of galectin-3 with HPS-1 or HPS-5,
captured photographs were cropped to include only individual cell’s
nuclei and surrounding cell body (n¼ 25). Dendrites were not
included in the cropped images. In the former group, the fluorescence
intensity per cell was quantified using the quantitative software
MetaMorph and expressed as signal intensity in the former group. In
the latter group, the color channels were separated, each of which
represented a different primary antibody: either galectin-3, HPS-1, or
HPS-5. Each color channel from each photograph was set on a
threshold value, and then the colocalization of each color was
measured. A t-test was done on the colocalization values comparing
galectin-3 with HPS-1 and galectin-3 with HPS-5 to test for a
significant difference between the primary antibodies.
Analysis of Mander’s coefficient
To quantify the Mander’s coefficient for colocalization of (a) galectin-
3 with Tyrp-1 or tyrosinase in cell bodies (20 cells per group) or (b)
galectin-3 with tyrosinase in HPS cells (25 cells per group), the
following was performed. Digital images were obtained using the
Zeiss LSM510 META confocal microscope. Using the quantitative
software Image J (NIH, Bethesda, MD), images were analyzed with
the Intensity Correlation Analysis plugin that generated Mander’s
coefficients. Mander’s overlap coefficient ranges between 1 and 0,
with 1 being high colocalization and 0 being low. Appropriate
thresholds were set for each image to eliminate noise.
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